MedTrace Logo

Facilitating Implementation of the PHS Smoking Cessation Guidelines - RESET

NCT00057070 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1900

Last updated 2015-04-07

No results posted yet for this study

Summary

The adverse impact of tobacco use on disease prevalence and health care costs is well documented. Hence, finding effective ways to reduce tobacco dependence is an essential component of improving the outcomes, quality and efficiency of VHA care. The U.S. Public Health Service (PHS) Smoking Cessation Clinical Practice Guideline provides specific recommendations for treating tobacco dependence. Despite their strong evidence base, however, these recommendations have not been fully integrated into clinical practice within the VHA. Recent data suggest that logistical difficulties associated with identifying and linking smokers with appropriate treatments may explain why the PHS Smoking Cessation Guideline has not been more broadly implemented.

Conditions

  • Smoking Cessation
  • Randomized Controlled Trial

Interventions

PROCEDURE

Smoking cessation information, collection, and dissemination

Sponsors & Collaborators

Principal Investigators

  • Melissa R. Partin, PhD · Minneapolis VA Health Care System, Minneapolis, MN

  • Anne M. Joseph, MD MPH · Minneapolis VA Health Care System, Minneapolis, MN

  • Bonnie G. Steele, PhD RN · VA Puget Sound Health Care System Seattle Division, Seattle, WA

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-10-31
Completion
2003-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00057070 on ClinicalTrials.gov